Australia: Draft Guidance on Evidence to Support Indications for Low Risk Medicines
Australia's Therapeutic Goods Administration (TGA) is seeking comment from interested parties on draft guidance Evidence Required to Support Indications for Listed Medicines (excluding sunscreens and disinfectants).
The draft specifies the type of evidence required to support indications made for listed (low risk) medicines (including weight loss products) and is intended to replace the Guidelines for Levels and Kinds of Evidence to Support Indications and Claims for Non-Registerable Medicines, including Complementary Medicines and other Listable Medicines.
Read more: